BTAI logo

BioXcel Therapeutics (BTAI) Total Liabilities

Annual Total Liabilities

$130.21 M
+$1.13 M+0.88%

December 31, 2023


Summary


Performance

BTAI Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBTAIbalance sheetmetrics:

Quarterly Total Liabilities

$134.53 M
-$5.21 M-3.73%

September 30, 2024


Summary


Performance

BTAI Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBTAIbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

BTAI Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.9%+3.3%
3 y3 years+883.5%+752.7%
5 y5 years+2694.2%+1350.1%

BTAI Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+632.7%-13.0%+690.2%
5 y5-yearat high+1271.1%-13.0%+1316.5%
alltimeall timeat high>+9999.0%-13.0%+9585.0%

BioXcel Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$134.53 M(-3.7%)
Jun 2024
-
$139.74 M(-9.7%)
Mar 2024
-
$154.69 M(+18.8%)
Dec 2023
$130.21 M(+0.9%)
$130.21 M(-7.7%)
Sep 2023
-
$141.06 M(+5.1%)
Jun 2023
-
$134.23 M(+5.6%)
Mar 2023
-
$127.10 M(-1.5%)
Dec 2022
$129.08 M(+626.3%)
$129.08 M(+9.5%)
Sep 2022
-
$117.83 M(+40.3%)
Jun 2022
-
$83.97 M(+393.2%)
Mar 2022
-
$17.02 M(-4.2%)
Dec 2021
$17.77 M(+34.2%)
$17.77 M(+12.7%)
Sep 2021
-
$15.78 M(+15.2%)
Jun 2021
-
$13.70 M(+0.3%)
Mar 2021
-
$13.65 M(+3.1%)
Dec 2020
$13.24 M
$13.24 M(-25.7%)
DateAnnualQuarterly
Sep 2020
-
$17.81 M(+4.4%)
Jun 2020
-
$17.07 M(+29.0%)
Mar 2020
-
$13.23 M(+39.3%)
Dec 2019
$9.50 M(+103.8%)
$9.50 M(+2.4%)
Sep 2019
-
$9.28 M(+1.7%)
Jun 2019
-
$9.12 M(+14.6%)
Mar 2019
-
$7.96 M(+70.8%)
Dec 2018
$4.66 M(+99.4%)
$4.66 M(+128.1%)
Sep 2018
-
$2.04 M(+47.1%)
Jun 2018
-
$1.39 M(-67.0%)
Mar 2018
-
$4.21 M(+80.4%)
Dec 2017
$2.34 M(+606.0%)
$2.34 M
Dec 2016
$331.00 K(-89.8%)
-
Jul 2016
$3.24 M(-26.5%)
-
Jul 2015
$4.40 M(+14.8%)
-
Jul 2014
$3.83 M
-

FAQ

  • What is BioXcel Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for BioXcel Therapeutics?
  • What is BioXcel Therapeutics annual total liabilities year-on-year change?
  • What is BioXcel Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for BioXcel Therapeutics?
  • What is BioXcel Therapeutics quarterly total liabilities year-on-year change?

What is BioXcel Therapeutics annual total liabilities?

The current annual total liabilities of BTAI is $130.21 M

What is the all time high annual total liabilities for BioXcel Therapeutics?

BioXcel Therapeutics all-time high annual total liabilities is $130.21 M

What is BioXcel Therapeutics annual total liabilities year-on-year change?

Over the past year, BTAI annual total liabilities has changed by +$1.13 M (+0.88%)

What is BioXcel Therapeutics quarterly total liabilities?

The current quarterly total liabilities of BTAI is $134.53 M

What is the all time high quarterly total liabilities for BioXcel Therapeutics?

BioXcel Therapeutics all-time high quarterly total liabilities is $154.69 M

What is BioXcel Therapeutics quarterly total liabilities year-on-year change?

Over the past year, BTAI quarterly total liabilities has changed by +$4.32 M (+3.31%)